Change Page Size of List
Page Size  
No record to display
Summary:

The Public Records Act does not require disclosure of any personal information including personal medical information, received or collected by a public agency regarding the employees, volunteers, board members, or contractors of a reproductive health services facility.

Summary:

If the accuracy of a syphilis test is challenged, the Department of Health Services must accept blood specimens for confirmation purposes.

Summary:

No tissues shall be transferred into the body of another person by means of transplantation, unless the donor of the tissues has been screened and found nonreactive by laboratory tests for evidence of infection with HIV, HBV and HCV (viral hepatitis), HTLV, and syphilis. The State Department of Health Services may adopt regulations requiring additional screening tests of donors of tissues when, the action is necessary for the protection of the public, donors, or recipients. Donors for tissue transplants must be screened by laboratory tests for HIV, viral hepatitis (HBV and HCV), and syphilis; and when applicable, for human T lympotrophic virus (HTLV). Such tissues can be transferred into the body of another person only if the donors test negative for infection. The State Department of Health Services may adopt regulations requiring additional screening tests of donors of tissues when necessary for the protection of the public, donors, or recipients.

Summary:

(2) A recipient of sperm may consent to therapeutic insemination of sperm or use of sperm in other assisted reproductive technologies even if the sperm donor is found reactive for hepatitis B, hepatitis C, syphilis, HIV, or HTLV if the sperm donor is the spouse of, partner of, or designated donor for that recipient. The physician providing insemination or assisted reproductive technology services shall advise the donor and recipient of the potential medical risks associated with receiving sperm from a reactive donor. The donor and the recipient shall sign a document affirming that each comprehends the potential medical risks of using sperm from a reactive donor for the proposed procedure and that each consents to it. Copies of the document shall be placed in the medical records of the donor and the recipient. . . . (3)(B)(IV) The recommendations made within the "Guidelines for Reducing the Risk of Viral Transmission During Fertility Treatment" published by the American Society for Reproductive Medicine regarding followup testing for HIV and HTLV after use of sperm from an HIV or HTLV reactive donor and have the recommendations regarding followup testing be documented in the recipient's medical record. (iv) The physician providing insemination or assisted reproductive technology services shall also verify, and document in the recipient' s medical record, that the donor of sperm who tests reactive for HIV or HTLV is under the care of a physician managing the HIV or HTLV. (v) The physician providing insemination or assisted reproductive technology services shall recommend to the physician who will be providing ongoing care to the recipient recommended followup testing for HIV and HTLV according to the "Guidelines for Reducing the Risk of Viral Transmission During Fertility Treatment" published by the American Society for Reproductive Medicine, which shall be documented in the recipient's medical record.

Summary:

(f) Notwithstanding subdivision (a), unless the patient requests the disclosure, the health care professional deems this disclosure as an appropriate means, and a health care professional has first discussed in person, by telephone, or by any other means of oral communication, the test results with the patient, in compliance with any other applicable laws, none of the following clinical laboratory test results and any other related results shall be disclosed to a patient by Internet posting or other electronic means: (1) HIV antibody test, unless an HIV test subject is anonymously tested and the test result is posted on a secure Internet Web site and can only be viewed with the use of a secure code that can access only a single set of test results and that is provided to the patient at the time of testing. The test result shall be posted only if there is no link to any information that identifies or refers to the subject of the test and the information required pursuant to subdivision (h) of Section 120990 is provided. (2) Presence of antigens indicating a hepatitis infection. (3) Abusing the use of drugs. (4) Test results related to routinely processed tissues, including skin biopsies, Pap smear tests, products of conception, and bone marrow aspirations for morphological evaluation, if they reveal a malignancy.

Summary:

The blood specimen obtained from a pregnant woman must be submitted to a laboratory for a syphilis test.

Now viewing : Page 1 of 1 first     previous     next     last